Differentiated outcomes start with differentiated design

The SAPIEN 3 Ultra valve is built on the proven SAPIEN 3 platform.

Edwards Commander delivery system

Predictability and control to meet the increasing complexity of your procedures.

Single-digit new permanent
pacemaker rates1

at 30 days
at 1 year
stroke rate

Resource Center

View All Resources


1. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695-1705.
2. Nazif T, Daniels D, McCabe J, Chehab B, et al. Real-world experience with the SAPIEN 3 Ultra TAVI: A propensity matched analysis from the United States. Presented virtually at TVT Connect 2020.
3. The PARTNER II Trial intermediate-risk cohort 30-day unadjusted clinical event rates for TAVR with the SAPIEN 3 valve, AT population (n=1077). Data on file.